RARE-51. RITUXIMAB, METHOTREXATE, BCNU, ETOPOSIDE, AND PREDNISONE (RMBVP) FOR THE TREATMENT OF RELAPSED/RECURRENT PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE SINGLE CE...

Tekijä Reiss, Samantha, Yerram, Prakirthi, Modelevsky, Lisa, Grommes, Christian
Julkaisussa Neuro Oncol (2019)

Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas

Tekijä Reiss, Samantha N., Yerram, Prakirthi, Modelevsky, Lisa, Grommes, Christian
Julkaisussa J Immunother Cancer (2017)

ACTR-94. TOXICITY OF SINGLE AGENT CARMUSTINE VERSUS CARMUSTINE PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT OR PROGRESSIVE HIGH GRADE GLIOMAS

Tekijä Yerram, Prakirthi, Reiss, Samantha, Modelevsky, Lisa, Gavrilovic, Igor, Kaley, Thomas
Julkaisussa Neuro Oncol (2017)

Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas

Tekijä Yerram, Prakirthi, Reiss, Samantha N, Modelevsky, Lisa, Gavrilovic, Igor T, Kaley, Thomas
Julkaisussa J Neurooncol (2019)

Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma

Tekijä Modelevsky, Lisa, Tizon, Richard, Reiss, Samantha N, Smith, Marcel, Garonce, Rachel, Kaley, Thomas
Julkaisussa CNS Oncol (2018)

Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City

Tekijä Yerram, Prakirthi, Thackray, Jennifer, Modelevsky, Lisa R, Land, Josiah D, Reiss, Samantha N, Spatz, Krisoula H, Levoir, Andrea C, Pak, Terry K, Dao, Phuong H, Buege, Michael J, Derespiris, Lauren M, Lau, Carmen, Orozco, Jennifer S, Boparai, Manpreet, Koranteng, Lauren A, Reichert, Kate E, Yan, Shirley Q, Daukshus, Nicole P, Mathew, Sherry, Buie, Larry W, Tizon, Richard F, Freeswick, Scott, Liu, Dazhi, Harnicar, Stephen
Julkaisussa J Oncol Pharm Pract (2021)